Price (delayed)
$2.9
Market cap
$310.16M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.88
Enterprise value
$444.15M
bluebird bio, Inc., based in Cambridge, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders and cancer. The company's only - in the European Union -
There are no recent dividends present for BLUE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.